Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
27,218,584
-
Share change
-
+3,149,769
-
Total reported value
-
$68,048,017
-
Put/Call ratio
-
53%
-
Price per share
-
$2.50
-
Number of holders
-
48
-
Value change
-
+$11,041,795
-
Number of buys
-
37
-
Number of sells
-
16
Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q4 2019
As of 31 Dec 2019,
AGILE THERAPEUTICS INC - COM (AGRX) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,218,584 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, INVESTOR AB, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Eversept Partners, LP, BlackRock Inc., Schonfeld Strategic Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, and EAM Investors, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.